Driving with arthritis pain: Stay comfortable — and safe — behind the wheel
Daily cup of coffee may prevent afib recurrence
Gene-editing therapy lowers harmful blood fats in early study
What is EMDR therapy, and who can it help?
GLP-1 drugs versus bariatric surgery for treating obesity
Two dumbbells, three exercises, and 10 minutes
Easing the emotional burden of IBS
Modify your push-ups to meet your fitness level
What is long QT syndrome?
Stroke survivors may benefit from very low LDL levels
Sarah Wakeman, MD, FASAM
Contributor
Dr. Sarah Wakeman is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team and a clinical lead of the Partners Healthcare Substance Use Disorder Initiative. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate of the American Board of Addiction Medicine. She is secretary for the Massachusetts Society of Addiction Medicine and chair of the policy committee. She previously served on Governor Baker’s Opioid Addiction Working Group.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her active research projects include a study evaluating the impact of addiction consultation on hospitalized medical patients with substance use disorder; a qualitative study exploring the role of recovery coaches for patients with substance use disorder; the healthcare cost and utilization impact of increased addiction treatment services across a health system; and the impact of a hospital-wide substance use disorder initiative on physician attitudes, preparedness, and clinical practice related to substance use disorder.
Posts by Sarah Wakeman, MD, FASAM
Sarah Wakeman, MD, FASAM
Lofexidine: Another option for withdrawal from opioids, but is it better?
Sarah Wakeman, MD, FASAM
Saving lives by prescribing naloxone with opioid painkillers
Sarah Wakeman, MD, FASAM
Fentanyl: The dangers of this potent “man-made” opioid
Driving with arthritis pain: Stay comfortable — and safe — behind the wheel
Daily cup of coffee may prevent afib recurrence
Gene-editing therapy lowers harmful blood fats in early study
What is EMDR therapy, and who can it help?
GLP-1 drugs versus bariatric surgery for treating obesity
Two dumbbells, three exercises, and 10 minutes
Easing the emotional burden of IBS
Modify your push-ups to meet your fitness level
What is long QT syndrome?
Stroke survivors may benefit from very low LDL levels